From December 2021 to May 2022, the Omicron BA. 1 and BA. 2 subvariants successively
became the most dominant strains in many countries around the world. Subsequently …

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that was first identified
in December 2019, in Wuhan, China was found to be the etiological agent for a novel …

Mass pathogen screening is critical to preventing the outbreaks and spread of infectious
diseases. The large‐scale epidemic of COVID‐19 and the rapid mutation of the severe acute …

To explore the mechanistic origin that determines the binding affinity of SARS-CoV-2 spike
receptor binding domain (RBD) to human angiotensin converting enzyme 2 (ACE2), we …

Emerging severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) variants,
especially the Omicron variant, have impaired the efficacy of existing vaccines and most …

Commencing in December 2019 with the emergence of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), three years of the coronavirus disease 2019 (COVID-19) …

Continual evolution of the severe acute respiratory syndrome coronavirus (SARS-CoV-2)
virus has allowed for its gradual evasion of neutralizing antibodies (nAbs) produced in …

The association between mean air temperature and new SARS-CoV-2 case numbers
throughout the ongoing coronavirus disease 2019 (COVID-19) pandemic was investigated …

Objectives To identify the SARS-CoV-2 variants Delta and Omicron during the fourth wave of
the COVID-19 pandemic in Mexico using samples taken from 19 locations in 18 out of the 32 …

Estimating the effective reproduction number of Omicron subvariants is crucial for evaluating
the effectiveness of control measures, and adjusting control measures promptly. We …